REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

CANbridge Pharmaceuticals Inc. (Hong Kong) (China)

Main Activities: Forestry and Logging | Wood Product Manufacturing | Management of Companies and Enterprises
Secondary Activities: Coal and Other Mineral and Ore Merchant Wholesalers
Full name: CANbridge Pharmaceuticals Inc. Profile Updated: March 16, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English & Chinese Download a sample report

Superb Summit International Group Limited is an investment holding company primarily engaged in the (i) exploitation and management of timber resources in China and (ii) marketing and sales of a wide range of timber products. The company was incorporated in 2001 and is headquartered in Hong Kong.

Headquarters
Unit A131, 16th Floor, Tower 5, The Gateway, Harbour City 15 Canton Road, Tsim Sha Tsui, Hong Kong
Hong Kong; Hong Kong;

Contact Details: Purchase the CANbridge Pharmaceuticals Inc. (Hong Kong) report to view the information.

Website: http://www.canbridgepharma.com

Basic Information
Total Employees:
Purchase the CANbridge Pharmaceuticals Inc. (Hong Kong) report to view the information.
Outstanding Shares:
Purchase the CANbridge Pharmaceuticals Inc. (Hong Kong) report to view the information.
Registered Capital:
Purchase the CANbridge Pharmaceuticals Inc. (Hong Kong) report to view the information.
Financial Auditors:
Purchase the CANbridge Pharmaceuticals Inc. (Hong Kong) report to view the information.
Incorporation Date:
January 29, 2001
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
Chief Financial Officer
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Director/Member of the Board
Ownership Details
Purchase this report to view the information.
7.5%
Purchase this report to view the information.
6.14%
Purchase this report to view the information.
2.36%
Purchase this report to view the information.
Purchase this report to view the information.
Subsidiaries
CAN bridge Pharmaceuticals Limited (Hong Kong SAR, China)
100%
CANbridge (Shanghai) Life Sciences Ltd.
100%
CANbridge (Suzhou) Bio-Pharma Co., Ltd.
100%
Company Performance
Financial values in the chart are available after CANbridge Pharmaceuticals Inc. (Hong Kong) report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CNY. Absolute financial data is included in the purchased report.
Net sales revenue
23.97%▲
Total operating revenue
48.53%▲
Operating profit (EBIT)
20.12%▲
EBITDA
22.82%▲
Net Profit (Loss) for the Period
12.39%▲
Total assets
-32.45%▼
Total equity
-75.64%▼
Operating Profit Margin (ROS)
252.46%▲
Net Profit Margin
210.29%▲
Return on Equity (ROE)
-127.6%▼
Debt to Equity Ratio
92.12%▲
Quick Ratio
-2.03%▼
Cash Ratio
-1.96%▼

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo